American in Biological Technology

New RISI Report Analyzes South American Tree Farm and Biomass Energy Investment Opportunities

BEDFORD, Mass., July 14 /PRNewswire/ -- RISI, the leading information provider for the global forest products industry, today announced the publication of the South American Tree Farm Update: Opportunities for Investment in Forest Industry and Biomass Energy Plantations . This new study upda...

Ten Top Latin American Scientists Named 2009 Pew Fellows in the Biomedical Sciences

PHILADELPHIA, June 16 /PRNewswire-USNewswire/ -- The Pew Charitable Trusts today named 10 promising young scientists as Pew Latin American Fellows in the Biomedical Sciences. The rigorously competitive program provides $60,000 in salary support for postdoctoral level scientists to work with...

Intarcia Therapeutics, Inc. Presents ITCA 650 Phase 1b Study Results as a Late-Breaker at the American Diabetes Association 69th Scientific Sessions

DUROS(R) continuous delivery of exenatide produces impressive reductions in fasting plasma glucose, HbA1c and body weight during 28-day treatment NEW ORLEANS, June 8 /PRNewswire/ -- Intarcia Therapeutics, Inc. today presented results from the first clinical study of ITCA 650 (DUROS(R) continu...

Orexigen(R) Therapeutics Presents Additional NB-302 Contrave(R) Data at American Diabetes Association (ADA) 69th Scientific Sessions

SAN DIEGO , June 6 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company focused on the treatment of obesity, today announced positive secondary findings from the first of four Phase 3 trials of its lead investigational product Contrave(R) (naltre...

Data for SemBioSys' insulin to be presented at the American Diabetes Association's 69th Scientific Sessions

CALGARY, June 5 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), specializing in the manufacture of high-value proteins and oils in plant seeds, today announced that it will present the recent results of the Phase I/II study with its biosimilar human insulin in a late-breaking scientifi...

VIA Pharmaceuticals' DGAT1 Inhibitors Featured in American Diabetes Association Poster Presentation

Preclinical Data Reported by Roche at 69th Scientific Sessions SAN FRANCISCO, June 4 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, announced toda...

Orexigen(R) Therapeutics Announces Upcoming Data Presentations at American Diabetes Association and Endocrine Society Annual Scientific Meetings

SAN DIEGO, June 2 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX ) a biopharmaceutical company focused on the treatment of obesity, today announced the schedule of its upcoming Contrave(R) (naltrexone sustained release (SR)/bupropion SR) presentations taking place at the ...

Leading North American Emergency Medical Services Provider British Columbia Ambulance Service Selects NICE Inform for Improved Service

RA'ANANA, Israel, June 2 /PRNewswire-FirstCall/ -- NICE Systems Ltd. (NASDAQ: NICE ), the global provider of advanced solutions that enable organizations to extract Insight from Interactions to drive performance, today announced that the British Columbia Ambulance Service (BCAS), the sole am...

Oncothyreon announces clinical data from three product candidates presented at American Society of Clinical Oncology (ASCO) Annual Meeting

SEATTLE, WA, May 30 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) (TSX:ONY) (the "Company") today announced that data from clinical trials for three of the Company's product candidates were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on May 30, 2009 i...

Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

HORSHAM, Pa., May 28 /PRNewswire/ -- Centocor Ortho Biotech Products, L.P. today announced that data related to several compounds will be presented at the 45th American Society of Clinical Oncology (ASCO) Annual Meeting in Orlando, Fla., from May 29 to June 2, 2009. The studies were sponsored by ...

MedMira Strengthens North American Sales Channels, Adding VWR as Distributor for the United States

HALIFAX, May 28 /PRNewswire-FirstCall/ - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF ), a developer and marketer of rapid diagnostic technology and solutions, announced today that VWR International, LLC (VWR) has joined the Company's U.S. distribution network. Headquartered in Wes...

Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions

First clinical study evaluating DUROS(R) continuous delivery of exenatide for the treatment of type 2 diabetes HAYWARD, Calif., May 27 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced it will present clinical data from a phase 1b study of ITCA 650 (DUROS(R) continuous delivery of e...

Senesco Presents Pre-Clinical Multiple Myeloma Data at the 12th Annual Meeting of the American Society of Gene Therapy

NEW BRUNSWICK, N.J., May 27 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT ) announced today that Richard Dondero, Vice President of Research and Development, will be presenting pre-clinical data from Senesco's multiple myeloma studies at...

Genomas and Institute of Living Among Organizers of Pharmacogenetics Symposium at 2009 Annual Meeting of the American Psychiatric Association

Field Moving Toward Genotype-Guided Psychotropic Therapy SAN FRANCISCO, May 21 /PRNewswire/ -- Gualberto Ruano, M.D., Ph.D., President of Genomas, and Director of Genetics Research at Hartford Hospital and Simon Kung, M.D., Assistant Professor of Psychiatry at the Mayo Clinic will co-chair a ...

deCODE Genotyping Laboratory Receives College of American Pathologists Accreditation

REYKJAVIK, Iceland, May 20 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN ) today announced that its CLIA-registered DNA isolation and genotyping laboratory, which processes the company's deCODEme(TM) personal genome scans and risk assessment diagnostic tests for several common disea...

Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology

Results Will be Reported from Phase 2 Studies Evaluating KRX-0401 in Advanced Renal Cell Carcinoma, Colorectal Cancer and Gastrointestinal Stromal Tumors (GIST) NEW YORK, May 18 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) today announced that four abstracts on ...

Oncothyreon announces presentations at American Society of Clinical Oncology (ASCO) Annual Meeting

SEATTLE, May 18 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) (TSX:ONY) today announced upcoming presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29-June 2, 2009 in Orlando, Florida. Abstracts related to our product candidates Stimuvax(R...

Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting

WAYNE, N.J. and EMERYVILLE, Calif., May 14 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that more than 65 studies evaluating the use of Nexavar(R) (sorafenib) tablets will be presented at the 2009 American Society...

Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting

ROCKVILLE, Md., May 14 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ) announced today that it will present posters on its newly approved atypical antipsychotic, Fanapt(TM) (iloperidone), at the 162nd American Psychiatric Association (APA) annual meeting in San Francisco, Ca...

OncoGenex Pharmaceuticals' Clinical Programs to be Featured in Oral Presentations at the American Society of Clinical Oncology Annual Meeting

BOTHELL, WA and VANCOUVER, May 11 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced today that final survival data from a randomized Phase 2 trial evaluating OGX-011 in combination with docetaxel versus docetaxel alone as first-line chemotherapy in patients with ...

ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons

MINNEAPOLIS, May 7 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced participation in the upcoming 89th Annual Meeting of the American Association for Thoracic Surgeons (AATS) being he...

NanoLogix Inc. to Exhibit at The American Society for Microbiology (ASM) General Meeting in Philadelphia; Announces Two New Patents

HUBBARD, Ohio, May 5 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (Pink Sheets: NNLX) NanoLogix personnel will display the company's BNP(TM) rapid-detection technology at booth 749 during the 109th Annual ASM Meeting to be held at the Pennsylvania Convention Center in Philadelphia May 17th - 21st. Th...

NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting

Evaluation of Neurologic Safety following Treatment with Qutenza(TM) (NGX-4010) Identification of Impact of PHN and PDN on Health Care Costs SAN MATEO, Calif., April 29 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX ), a biopharmaceutical company focused on developing and co...

Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology

- Updated Survival and Biomarker Data for Ipilimumab to be Presented - PRINCETON, N.J., April 29 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) announced today that the following clinical abstracts for ipilimumab in melanoma and prostate cancer, as well as for an anti-PD-1 antibody...

Trubion Presents Preclinical Data on Its SCORPION(TM) Multispecific Therapeutics at the 2009 American Association of Cancer Research Annual Meeting

SEATTLE, April 22 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN ) announced today presentation of preclinical data regarding its SCORPION(TM) multispecific therapeutic technology at the 100th Annual Meeting of the American Association of Cancer Research (AACR) in Denver. ...

Mach One BioPharm Process Operating Group Receives Contract From American Beef Processors

BELGIUM, Wis., April 22 /PRNewswire-FirstCall/ -- Mach One Corporation (Pink Sheets: MNCN), an innovative, global wellness solutions company, announces that its BioPharm Process Systems operating group (BPS), operating under the MPS-BioPharm name (MPS), received both a contract and deposit from A...

Keryx Biopharmaceuticals Presents Encouraging Preclinical Data at Annual Meeting of the American Association of Cancer Research

Data Selected for Presentation Highlights Anti-Tumor effects of KRX-0401 (Perifosine) NEW YORK, April 21 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) today announced multiple presentations of preclinical data highlighting the anti-tumor effects of KRX-0401 (perif...

Isis and Partners Present New Research at the American Association for Cancer Research 2009 Annual Meeting

DENVER and CARLSBAD, Calif., April 20 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced today that Isis and its collaborators presented results on antisense inhibition of novel targets that could offer new mechanisms to treat cancer during the American Association fo...

Quark Pharmaceuticals to Present at American Society for Pharmacology and Experimental Therapeutics Annual Meeting

FREMONT, Calif., April 20 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that James D. Thompson, Ph.D., Vice President, Pharmaceutical Development, will give a pres...

Genstruct to Present Results of Collaboration with Top Pharmaceutical Company at American Association for Cancer Research's Annual Meeting

DENVER and CAMBRIDGE, Mass., April 14 /PRNewswire/ -- ( AACR 100th Annual Meeting 2009 ) - Genstruct Inc. , a systems biology company focused on identifying molecular mechanisms, networks and biomarkers to better develop novel therapeutics, molecular diagnostics and patient-specific therapies...

Poniard Pharmaceuticals to Present Final Data from Picoplatin Phase 1 Clinical Trials at American Association for Cancer Research's 100th Annual Meeting

-- Phase 1 Data from Colorectal Cancer and Oral Picoplatin Trials To Be Presented -- SOUTH SAN FRANCISCO, Calif., April 14 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on oncology, today announced that the Company will present ...

Council for American Medical Innovation Brings U.S. Leaders in Medicine, Biotechnology and Discovery Together in Chicago for 'Best and Brightest Forum on Medical Innovation'

CHICAGO, April 7 /PRNewswire-USNewswire/ -- The following release is being issued by Council for American Medical Innovation: (Logo: http://www.newscom.com/cgi-bin/prnh/20090325/DC89081LOGO ) WHAT: A forum for discussion on the importance of medical science and discovery in the...

University of Minnesota Professor Dr. David Pui to Speak at American Filtration and Separation Society Conference

The American Filtration and Separations Society (AFS) will be holding its 22nd Annual Conference, May 4-7, 2009 at the Sheraton Hotel in Bloomington Minnesota. Minneapolis, MN (PRWEB) April 7, 2009 -- The American Filtration and Separations Society (AFS) will be hol...

Immunotech Laboratories Announces South American Strategy

GLENDALE, Calif., April 3 /PRNewswire-FirstCall/ -- Immunotech Laboratories (Pink Sheets: IMMB) is happy to announce preliminary discussions in setting up a potential venture for South America, headquartered in Mexico. According to Ara Ghanime, Chairman of Immunotech Laboratories, the poten...

The American Medical Association and Elsevier Join to Co-Publish ICD-9-CM and HCPCS Coding Reference Books

CHICAGO and ST. LOUIS, Missouri, March 31 /PRNewswire-FirstCall/ -- - Books Authored by Noted Coding Author Carol J. Buck Two of the biggest names in health care publishing, the American Medical Association (AMA) and Elsevier have announced an exclusive agreement to co-publish I...

New Discoveries on a Fingertip Test for Screening Silent Heart Disease Promising Results of Recent Clinical Studies to be Presented during the 2009 American College of Cardiology Conference, March 29th - April 1st in Orlando

Results of five clinical studies evaluating the predictive value of VENDYS®, the new FDA-approved cardiovascular test, will be presented at the 2009 Annual Scientific Sessions of the American College of Cardiology in Orlando, Florida. The studies, amazingly, show that a simple, inexpensive te...

Cytopia Scientific Presentation on JAK2 Inhibitor Program at American Chemical Society Conference

MELBOURNE, Australia, March 23 /PRNewswire/ -- Cytopia Limited (ASX: CYT) today announced that it will present data on its JAK2 program at the American Chemical Society Spring meeting, currently underway in Salt Lake City, Utah, USA. Dr Tracy Nero, Senior Scientist at Cytopia, will be presen...

Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research

PRINCETON, N.J., March 17 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) announced today that the following clinical and preclinical abstracts are expected to be the subject of poster presentations at the Annual Meeting of the American Association for Cancer Research (AACR), being held ...

Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning

CHELMSFORD, Mass., March 17 /PRNewswire/ -- Magellan Biosciences, an emerging leader in systems for clinical-diagnostics, will receive the Frost & Sullivan 2009 North American Product Innovation Award for LeadCare II, a rapid, point-of-care test that enables children and adults to be screened ...

Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research

BETHESDA, Md., March 16 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the publication of six abstracts for poster presentations at t...